中大機構典藏-NCU Institutional Repository-提供博碩士論文、考古題、期刊論文、研究計畫等下載:Item 987654321/57758
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 80990/80990 (100%)
造访人次 : 42712401      在线人数 : 1386
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.lib.ncu.edu.tw/handle/987654321/57758


    题名: 環狀核苷磷酸二酯酶4對LPS刺激小鼠巨噬細胞產生IP-10之影響;Effects of Phosphodiesterase 4 on LPS-stimulated IFNγ-induced Protein 10 Production in Mouse Macrophages
    作者: 黃珮瑜;Huang,Pei-yu
    贡献者: 生命科學系
    关键词: 干擾素γ誘導蛋白-10;環狀核苷酸磷酸二酯酶4;環磷酸腺苷;巨噬細胞;T細胞;趨化作用;cAMP;chemotaxis;IP-10;macrophages;PDE4;T cells
    日期: 2012-10-22
    上传时间: 2012-11-12 14:27:27 (UTC+8)
    出版者: 國立中央大學
    摘要: 趨化激素IFNγ-induced protein 10(IP-10)又稱為CXCL10,可由多種免疫及非免疫細胞所產生,它與許多發炎和自體免疫疾病有關。文獻指出,不同的促發炎介質包括LPS會刺激巨噬細胞釋放IP-10,然而目前對IP-10產生的調控機制還不太清楚。已知在多數發炎細胞中活化cAMP的訊息傳導可有效抑制細胞激素的產生,而分解cAMP的磷酸二酯?PDE4在發炎細胞中為調控cAMP濃度的主要酵素。因此,本研究主要的目的是想探討在巨噬細胞中PDE4是否參與調控IP-10的產生以及它的作用機制。利用LPS處理Raw 264.7 和小鼠腹腔巨噬細胞,我們發現IP-10的釋放會隨著時間和濃度的增加而上升,而PDE4抑制劑rolipram會有效的抑制IP-10的釋放,其IC50分別約為0.2 μM 和 0.02 μM。同時,Rolipram也會抑制IP-10 mRNA的表現。再者, 以PKA活化劑6-Bnz-cAMP處理巨噬細胞,其LPS刺激IP-10的釋放也會隨著藥劑濃度的增加而下降,然而Epac活化劑8-pCPT-2’-O-Me-cAMP只在高濃度時才有部分抑制作用。此外,PKA inhibitor Rp-8-CPT-cAMPS也會部份回復rolipram對IP-10的抑制作用。由這些結果顯示,rolipram對IP-10的抑制主要是藉由活化cAMP/PKA的路徑所致。我們進一步利用LPS處理PDE4基因剔除小鼠之腹腔巨噬細胞,發現PDE4B-/-細胞釋放IP-10會顯著下降,且其下降程度與rolipram處理PDE4B+/+巨噬細胞相當,同時rolipram不再進一步抑制PDE4B-/-巨噬細胞釋放IP-10。PDE4A-/-與PDE4D-/-細胞其IP-10的反應與PDE4A+/+與PDE4D+/+細胞一致。這些結果證明rolipram對IP-10的抑制作用是由於抑制PDE4B活性所致。另外,利用小鼠脾臟T細胞進行趨化反應,結果顯示IP-10誘導T細胞的移動也會被rolipram抑制。?合以上結果得知,在小鼠巨噬細胞中PDE4B對LPS刺激IP-10的產生與釋放是不可或缺的,且剔除或抑制PDE4B活性會活化cAMP/PKA訊息傳導進而抑制IP-10的反應。IFNγ-induced protein 10 (IP-10), also known as CXCL10, is a chemokine that can be produced by a variety of immune and non-immune cells during an inflammatory condition, and is associated with several inflammatory disorders. Accumulating evidence indicates that IP-10 is secreted by macrophages in response to various pro-inflammatory mediators, including lipopolysaccharide(LPS). The regulatory mechanism underlying the production of IP-10, however, remains unclear. Activation of cAMP signaling is known to have negatively modulatory effects on cytokine production in most inflammatory cells. Type 4 phosphodiesterases(PDE4), the enzymes responsible for cAMP degradation, play a key role in regulation of cAMP concentration in inflammatory cells. Thus, in this study, we aimed to determine whether and how PDE4 is involved in regulation of IP-10 production in macrophages in response to LPS. By stimulation of Raw 264.7 and mouse peritoneal macrophages with LPS, we observed that the IP-10 release increased in a time- and dose-dependent manner, and the PDE4 inhibitor rolipram effectively suppressed the IP-10 release with the IC50 of approximately 0.2 μM and 0.02 μM, respectively. The inhibition of IP-10 by rolipram was also obtained at the transcriptional level. Additionally, the LPS-induced IP-10 release was does-dependently inhibited by the PKA activator 6-Bnz-cAMP, but less effectively by the Epac activator 8-pCPT-2’-O-Me-cAMP. Moreover, the rolipram-inhibited IP-10 release was partially reversed by the PKA inhibitor Rp-8-CPT-cAMPS. These results indicated that the effect of rolipram on the IP-10 response was primarily mediated by the PKA activation. Using PDE4-deficient peritoneal macrophages treated with LPS, we found that the release of IP-10 in PDE4B-/- macrophages, but not PDE4A-/- or PDE4D-/- macrophages, was significantly decreased, to the level similar to that in the PDE4B+/+ macrophages treated with rolipram. Moreover, rolipram did not further decrease the IP-10 release in PDE4B-/- macrophages. These results demonstrated that the effect of rolipram on the IP-10 release was mediated by inhibition of PDE4B activity. Using mouse splenic T cells in a chemotactic reaction, we found that the IP-10-induced migration of T cells was also attenuated by rolipram. Taken together, these findings demonstrate that PDE4B is essential in the LPS-stimulated IP-10 production in mouse macrophages, and by activation of cAMP/PKA signaling ablation or inhibition of PDE4B can downregulate the IP-10 response.
    显示于类别:[生命科學研究所 ] 博碩士論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML906检视/开启


    在NCUIR中所有的数据项都受到原著作权保护.

    社群 sharing

    ::: Copyright National Central University. | 國立中央大學圖書館版權所有 | 收藏本站 | 設為首頁 | 最佳瀏覽畫面: 1024*768 | 建站日期:8-24-2009 :::
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 隱私權政策聲明